The Westminster lensArchive · Written questions · 211 tabled · 197 answered

Written questions by Smith.

Every parliamentary written question tabled by Cat Smith this session, with the full answer and department. See how every department answers, or back to the MP page.

Department:All (211)Department of Health and Social Care (67)Department for Culture, Media and Sport (21)Foreign, Commonwealth and Development Office (19)Department for Business and Trade (16)Home Office (16)Department for Environment, Food and Rural Affairs (12)Department for Transport (11)Department for Education (11)Ministry of Justice (6)Department for Work and Pensions (6)Ministry of Housing, Communities and Local Government (5)Department for Science, Innovation and Technology (3)

Showing 4160 of 67 · Department of Health and Social Care

← PreviousPage 3 of 4Next →
13 Mar 2025·Department of Health and Social Care·Answered
Asked

What steps he is taking with Cabinet colleagues to support women with epilepsy.

Reply

The Government is committed to prioritising women’s health, placing women’s equality at the heart of our agenda and ensuring women’s health is never again neglected.At a national level, there are several initiatives supporting service improvement and better care for patients with epilepsy, including women, such as the RightCare Epilepsy Toolkit, and the Getting It Right First Time Programme (GIRFT) for Neurology and the Neurology Transformation Programme (NTP).The GIRFT National Specialty Report made recommendations designed to improve services nationally and to support the National Health Service to deliver care more equitably across the country. The National Specialty Report highlighted differences in how services are delivered and offered an unprecedented opportunity to share successful initiatives between trusts to improve patient services nationally.Building on the GIRFT National Specialty Report, the NTP has developed a model of integrated care for neurology services to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients, including providing care closer to home. A toolkit is being developed to support ICBs to understand and implement this new model.The RightCare Epilepsy Toolkit includes specific recommendations regarding supporting women with epilepsy. For example, it states that support should be provided to women with epilepsy who are pregnant and those who are of childbearing age which makes clear the risks of certain anti-epileptic drugs that are known to cause birth defects, such as sodium valproate.The Toolkit also makes clear that it is equally important to provide clear information and guidance on the risks of stopping an anti-epileptic drug treatment, which include Sudden Unexpected Death in Epilepsy, that is not related to causing birth defects, and the risks that poses to the mother and unborn baby to support balanced informed decisions on care.

13 Feb 2025·Department of Health and Social Care·Answered
Asked

With reference to the Answer of 27 January 2021 to Question 137239 on Prescription Drugs, what information his Department holds on the number of patients who have been prescribed drugs categorised under the (a) (i) clonazepam and (ii) other benzodiazepines, (b) z-drugs, (c) antidepressants, (d) opioids, (e) pregabalin and (f) gabapentin drug groups in the (A) last 12 months and (B) the previous 12 month period for which data is available.

Reply

The following table shows the number of items dispensed and claimed for reimbursement for each of the categories requested, covering the most recently published 12-month period and the 12 months prior:Drug groupFinancial yearTotal number of itemsClonazepam2022/231,048,0812023/241,059,421Other benzodiazepines2022/237,156,8452023/246,814,129Clonazepam and other benzodiazepines2022/238,204,9262023/247,873,550Z-drugs2022/235,316,6272023/245,113,574Antidepressants2022/2386,263,7222023/2489,131,582Opioids2022/2339,401,5172023/2439,046,206Pregabalin2022/238,775,6992023/249,180,793Gabapentin2022/237,413,7592023/247,408,375Source: NHS Business Services Authority.In addition, the following table shows the patient identifiable information for the number of items dispensed and claimed for reimbursement for each of the categories requested, for the most recently published 12-month period and the 12 months prior:Drug groupFinancial YearTotal number of unique identified patientsPercentage of items where the patient has been identifiedClonazepam2022/2385,61398.22%2023/2485,19198.16%Other benzodiazepines2022/231,253,96297.06%2023/241,186,00197.01%Clonazepam and other benzodiazepines2022/231,324,79297.21%2023/241,256,94197.17%Z-drugs2022/23795,959 98.29%2023/24764,743 98.27%Antidepressants2022/238,563,148 99.16%2023/248,747,095 99.22%Opioids2022/235,593,035 98.92%2023/245,562,718 98.94%Pregabalin2022/23786,403 99.36%2023/24823,231 99.41%Gabapentin2022/23808,562 99.36%2023/24799,144 99.41Source: NHS Business Services Authority.Notes:for clonazepam and other benzodiazepines, this is the number of unique patients who have received any combination of clonazepam and/or other benzodiazepines, and no patient is counted twice even where multiple medications have been received;the figures for pregabalin and gabapentin refer to the combined category of gabapentinoids; andthe data in this answer in both tables on opioids, is not directly comparable to data from the previous Parliamentary Questions, PQ137238 and PQ137239, referenced in the question, as these tables refer to opioids in general, while the previous Parliamentary Questions referred to opioid analgesics only.

13 Feb 2025·Department of Health and Social Care·Answered
Asked

How many prescriptions were issued for each drug categorised under the (a) (i) clonazepam and (ii) other benzodiazepines, (b) z-drugs, (c) antidepressants, (d) opioids, (e) pregabalin and (f) gabapentin drug groups in the (i) last 12 months and (ii) previous 12 month period for which data is available.

Reply

The following table shows the number of items dispensed and claimed for reimbursement for each of the categories requested, covering the most recently published 12-month period and the 12 months prior:Drug groupFinancial yearTotal number of itemsClonazepam2022/231,048,0812023/241,059,421Other benzodiazepines2022/237,156,8452023/246,814,129Clonazepam and other benzodiazepines2022/238,204,9262023/247,873,550Z-drugs2022/235,316,6272023/245,113,574Antidepressants2022/2386,263,7222023/2489,131,582Opioids2022/2339,401,5172023/2439,046,206Pregabalin2022/238,775,6992023/249,180,793Gabapentin2022/237,413,7592023/247,408,375Source: NHS Business Services Authority.In addition, the following table shows the patient identifiable information for the number of items dispensed and claimed for reimbursement for each of the categories requested, for the most recently published 12-month period and the 12 months prior:Drug groupFinancial YearTotal number of unique identified patientsPercentage of items where the patient has been identifiedClonazepam2022/2385,61398.22%2023/2485,19198.16%Other benzodiazepines2022/231,253,96297.06%2023/241,186,00197.01%Clonazepam and other benzodiazepines2022/231,324,79297.21%2023/241,256,94197.17%Z-drugs2022/23795,959 98.29%2023/24764,743 98.27%Antidepressants2022/238,563,148 99.16%2023/248,747,095 99.22%Opioids2022/235,593,035 98.92%2023/245,562,718 98.94%Pregabalin2022/23786,403 99.36%2023/24823,231 99.41%Gabapentin2022/23808,562 99.36%2023/24799,144 99.41Source: NHS Business Services Authority.Notes:for clonazepam and other benzodiazepines, this is the number of unique patients who have received any combination of clonazepam and/or other benzodiazepines, and no patient is counted twice even where multiple medications have been received;the figures for pregabalin and gabapentin refer to the combined category of gabapentinoids; andthe data in this answer in both tables on opioids, is not directly comparable to data from the previous Parliamentary Questions, PQ137238 and PQ137239, referenced in the question, as these tables refer to opioids in general, while the previous Parliamentary Questions referred to opioid analgesics only.

21 Jan 2025·Department of Health and Social Care·Answered
Asked

If he will make an assessment of the impact of the restriction of puberty blockers for the treatment of gender incongruence on the (a) physical and (b) mental health of young trans people.

Reply

On 11 December 2024 the Government introduced The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024, which came into effect on 1 January 2025. Alongside this legislation the Government published a full impact assessment, which is available at the following link:https://www.legislation.gov.uk/uksi/2024/1319/impacts

11 Dec 2024·Department of Health and Social Care·Answered
Asked

Whether he plans to meet (a) the Alcohol Health Alliance and (b) other public health representatives to discuss rates of alcohol harm.

Reply

Under our Health Mission, the Government is committed to prioritising preventative public health measures to support people to live longer, healthier lives. For too long there has been an unwillingness to lead on issues like smoking, alcohol harm, and obe...

11 Dec 2024·Department of Health and Social Care·Answered
Asked

How many alcohol industry representatives Ministers in his Department have met since July 2024.

Reply

Details of ministers’ meetings with external individuals and organisations are published quarterly in arrears on GOV.UK website. Data for the period of July to September 2024 will be published in due course.

11 Dec 2024·Department of Health and Social Care·Answered
Asked

If he will meet the Alcohol Health Alliance to discuss what steps the Government can take to reduce alcohol related deaths.

Reply

Under our Health Mission, the Government is committed to prioritising preventative public health measures to support people to live longer, healthier lives. For too long there has been an unwillingness to lead on issues like smoking, alcohol harm, and obe...

11 Dec 2024·Department of Health and Social Care·Answered
Asked

What steps the Health Mission Board has taken to tackle rates of alcohol harm.

Reply

Under our Health Mission, the Government is committed to prioritising preventative public health measures to support people to live longer, healthier lives. For too long there has been an unwillingness to lead on issues like smoking, alcohol harm, and obe...

11 Dec 2024·Department of Health and Social Care·Answered
Asked

What steps he plans to take to tackle alcohol harms.

Reply

Under our Health Mission, the Government is committed to prioritising preventative public health measures to support people to live longer, healthier lives. For too long there has been an unwillingness to lead on issues like smoking, alcohol harm, and obe...

11 Dec 2024·Department of Health and Social Care·Answered
Asked

How many public health representatives he has met to discuss (a) tobacco, (b) obesity and (c) alcohol harm; and whether he plans to meet more public health organisations in the New Year to discuss

Reply

Details of ministers’ meetings with external individuals and organisations are published quarterly in arrears on GOV.UK website. Data for the period of July to September 2024 will be published in due course.I can confirm that Department ministers expect t...

18 Nov 2024·Department of Health and Social Care·Answered
Asked

Whether he plans to announce the future funding for drug and alcohol treatment provision as part of the Drugs Strategy in time for services to avoid commencing redundancy consultations; and if he w

Reply

The Government supports investment in drug and alcohol treatment and recovery services, to ensure that those people with a substance use need get appropriate help and support. In addition to the Public Health Grant, the Department has allocated local auth...

18 Nov 2024·Department of Health and Social Care·Answered
Asked

When he plans to announce (a) whether Drug Strategy funding for drug and alcohol treatment providers will be renewed and at what levels and (b) the length of the funding cycle; and if he will take

Reply

The Government supports investment in drug and alcohol treatment and recovery services, to ensure that those people with a substance use need get appropriate help and support. In addition to the Public Health Grant, the Department has allocated local auth...

18 Nov 2024·Department of Health and Social Care·Answered
Asked

When he plans to announce (a) allocations of public health grants to local authorities and (b) the length of the funding cycle; and if he will take steps to ensure that local authorities have adequ

Reply

We will publish local authority public health grant allocations for 2025/26 in due course, with the aim of giving local authorities as much notice as possible to plan.We will aim to confirm future multi-year allocations later in 2025, following the next p...

21 Oct 2024·Department of Health and Social Care·Answered
Asked

What estimate his Department has made of the cost of Lancashire and South Cumbria New Hospitals Programme scheme.

Reply

The standard process confirming the total funding amount for major infrastructure projects involves the review and approval of a Full Business Case. All trusts in the programme have previously received indicative funding allocations to support planning, h...

21 Oct 2024·Department of Health and Social Care·Answered
Asked

How much funding the Lancashire and South Cumbria New Hospitals Programme scheme had received up to the end of the 2023-24 financial year.

Reply

The standard process confirming the total funding amount for major infrastructure projects involves the review and approval of a Full Business Case. All trusts in the programme have previously received indicative funding allocations to support planning, h...

21 Oct 2024·Department of Health and Social Care·Answered
Asked

How much funding had been allocated by the Treasury for the Lancashire and South Cumbria New Hospitals Programme scheme by 2 July 2024.

Reply

The standard process confirming the total funding amount for major infrastructure projects involves the review and approval of a Full Business Case. All trusts in the programme have previously received indicative funding allocations to support planning, h...

21 Oct 2024·Department of Health and Social Care·Answered
Asked

What the (a) business case status and (b) RIBA stage is of the Lancashire and South Cumbria New Hospitals Programme scheme.

Reply

The standard process confirming the total funding amount for major infrastructure projects involves the review and approval of a Full Business Case. All trusts in the programme have previously received indicative funding allocations to support planning, h...

4 Oct 2024·Department of Health and Social Care·Answered
Asked

Whether he has made an assessment of the adequacy of the availability at pharmacies of methylphenidate medication for people with ADHD.

Reply

The Department monitors and manages medicine supply at a national level so that stocks remain available to meet regional and local demand. Information is not collected on a local level.The Department has been working hard with industry and NHS England to ...

4 Oct 2024·Department of Health and Social Care·Answered
Asked

Whether he has made an assessment of the adequacy of the availability of anti-convulsant medicines to control epilepsy.

Reply

The Department is working hard with industry to help resolve intermittent supply issues with some epilepsy medications. As a result of ongoing activity and intensive work, including directing suppliers to expedite deliveries, some issues, including with s...

30 Jul 2024·Department of Health and Social Care·Answered
Asked

Whether he plans to take steps to help ensure mental health services are accessible to patients in rural communities.

Reply

As set out in the NHS Priorities and Operational Planning Guidance for 2024/25, NHS England is continuing to expand access to mental health services, to increase the number of people accessing mental health support. Integrated care boards are responsible ...

← PreviousPage 3 of 4Next →
Sources
SourceUK Parliament Members API
MethodQuestion and answer text as published. Question preamble (“To ask the…”) trimmed for readability; answers shown in full.